Ochre Bio
Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. The Oxford-based company has raised $40M in Series A funding and employs 61 people.
The growth story
Ochre Bio grew from 18 to 61 employees between 2021 and 2026, raising $40M along the way, most recently a Series A in October 2022.
About
Ochre Bio develops RNA-based treatments for chronic liver conditions using genomic analysis and testing in live human donor livers. Its therapies aim to expand donor liver availability and reduce complications from cirrhosis.
The company raised $40M in Series A funding in October 2022, backed by investors including Apollo Health Ventures and Bioverge. With 61 employees, Ochre Bio draws heavily on talent from Oxford University and major pharmaceutical firms like Novo Nordisk and GSK.
Founders and leadership
Research is Ochre Bio's largest function, accounting for 27 of its 61 employees. The company is led by a team with backgrounds in biotechnology and pharmaceuticals, with a median tenure of 2 years.
The Ochre Bio org chart
Quin Wills (Founder and CEO) leads 19 mapped leaders with 3 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 38 (-7% YoY), Operations 4 (+100% YoY), Entrepreneurship 3 (0% YoY), Business Development 3 (-40% YoY).
Talent flow
Ochre Bio recruits heavily from Oxford University, which accounts for 6 of its 51 analyzed profiles. Other key talent sources include Memorial Sloan Kettering Cancer Center and Novo Nordisk. Alumni have moved to companies like Aerska and Tempus AI.
Most common previous employers of Ochre Bio staff: University of Oxford (6), Memorial Sloan Kettering Cancer Center (5), Novo Nordisk (4), Weill Cornell Medicine (4), GSK (3), National Taiwan University (3). Former Ochre Bio employees most often moved to Aerska (4), Deloitte (1), The Bits in Bio Podcast (1), OXECO (1), CatSci (1), Tempus AI (1).
Alumni worth knowing
The Ochre Bio mafia
Ochre Bio alumni have founded 4 companies, including Aerska, which employs 29 people, and OXECO, with 19 staff. Other ventures include Gramics Bio and factorize.bio.
4Jack O'Meara, was CEO, Co-founder until 2024Vassilis Ragoussis, was Program Manager/Commercial Operations until 2021Alice Preston, was Principal Scientist until 2023Jörn Schmiedel, was Lead Data Sciencist until 2022Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Ochre Bio: Molecular Biology (20), Data Analysis (20), Cell Culture (19), Research Skills (19), Communication (15), Western Blotting (14), Cell Biology (14), Leadership (14).
Where the team actually sits
Ochre Bio people are concentrated in England, United Kingdom (16), New York, United States (11), United Kingdom (7), Greater Oxford Area (4).
Search footprint
Ochre Bio attracts about 44 organic search visits a month, traffic worth roughly $1K a month if bought through ads. It gained 8 ranking keywords and lost 10 in the last period.
What employees say
- Compensation
- 5.00 / 5
- Career opportunities
- 4.60 / 5
- Senior management
- 5.00 / 5
- Work-life balance
- 5.00 / 5
Frequently asked
Ochre Bio has 61 employees as of September 2026.
Ochre Bio has raised $40M in total, most recently a Series A round in October 2022.
Ochre Bio was founded in 2019 by Quin Wills.
Quin Wills (Founder and CEO) sits at the top of Ochre Bio's reporting structure, with 3 direct reports.
The most common previous employers of current Ochre Bio staff are University of Oxford (6 people), Memorial Sloan Kettering Cancer Center (5 people), Novo Nordisk (4 people).
Former Ochre Bio employees most often move to Aerska (4), Deloitte (1), The Bits in Bio Podcast (1).
At least 4 companies have a founder who previously worked at Ochre Bio, including Aerska, OXECO, Gramics Bio.
Ochre Bio attracts about 44 organic search visits a month, worth roughly $1K a month in equivalent ad spend.
The most common skills among Ochre Bio staff are Molecular Biology, Data Analysis, Cell Culture, Research Skills, Communication.
Ochre Bio staff are concentrated in England, United Kingdom (16), New York, United States (11), United Kingdom (7).
Ochre Bio has about 38 people in Research, down 7% over the past year, as of September 2026.
Ochre Bio has about 4 people in Operations, up 100% over the past year, as of September 2026.
Computed from 51 current and 52 former Ochre Bio profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.